Results 1 to 10 of about 1,254,090 (295)

Tumor site immune markers associated with risk for subsequent basal cell carcinomas. [PDF]

, 2011
BackgroundBasal cell carcinoma (BCC) tumors are the most common skin cancer and are highly immunogenic.ObjectiveThe goal of this study was to assess how immune-cell related gene expression in an initial BCC tumor biopsy was related to the appearance of ...
Andridge, Rebecca, Bechtel, Mark A, Chen, Min, De Renne, Lawrence A, Di Gregorio, Michael, Glaser, Ronald, Hearne, Dean W, Herron, Joel Bain, Jewell, Scott D, Johnson, Sheri L, Kiecolt-Glaser, Janice K, Lambert, David R, Shana'ah, Arwa Y, Yang, Eric V   +13 more
core   +17 more sources

Application of Janus Particles in Point-of-Care Testing

Biosensors, 2022
Janus particles (JPs), named after the two-faced Roman god, are asymmetric particles with different chemical properties or polarities. JPs have been widely used in the biomedical field in recent years, including as drug carriers for targeted controlled ...
Yuhan Wang, Peixuan Zhao, Shihao Zhang, Kexiao Zhu, Xiaoya Shangguan, Lishang Liu, Shusheng Zhang   +6 more
doaj   +1 more source

Liquid Crystal Droplet-Based Biosensors: Promising for Point-of-Care Testing

Biosensors, 2022
The development of biosensing platforms has been impressively accelerated by advancements in liquid crystal (LC) technology. High response rate, easy operation, and good stability of the LC droplet-based biosensors are all benefits of the long-range ...
Ruwen Xie, Na Li, Zunhua Li, Jinrong Chen, Kaixuan Li, Qiang He, Lishang Liu, Shusheng Zhang   +7 more
doaj   +1 more source

Tumor Markers [PDF]

Molecular & Cellular Proteomics, 2003
Abstract One of the questions most frequently asked of physicians by patients concerns prognosis. Markers of solid tumors are the best prognosticators of the course of these tumors. The effect of these markers on the host will have a substantial impact on prognosis by affecting the performance status of the patient.
Anne-Sofie Schrohl, Mads Holten-Andersen, Fred Sweep, Manfred Schmitt, Nadia Harbeck, John Foekens, Nils Brünner   +6 more
openaire   +2 more sources

LGR5 is associated with tumor aggressiveness in papillary thyroid cancer. [PDF]

, 2015
PurposeLeucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5) is a cancer stem cell marker and a down-stream target in Wnt/β-catenin signaling. In human papillary thyroid cancer (PTC), over activation of Wnt/β-catenin has been associated with
Diehl, Anna Mae, Henderson, Brittany Bohinc, Jiang, Xiaoyin, Michelotti, Gregory, Sosa, Julie Ann   +4 more
core   +6 more sources

Conjugated Polymeric Materials in Biological Imaging and Cancer Therapy

Molecules, 2023
Conjugated polymers (CPs) have attracted much attention in the fields of chemistry, medicine, life science, and material science. Researchers have carried out a series of innovative researches and have made significant research progress regarding the ...
Qinbin Zheng, Zhuli Duan, Ying Zhang, Xinqi Huang, Xuefan Xiong, Ang Zhang, Kaiwen Chang, Qiong Li   +7 more
doaj   +1 more source

Aptamer Functionalized Upconversion Nanotheranostic Agent With Nuclear Targeting as the Highly Localized Drug-Delivery System of Doxorubicin

Frontiers in Bioengineering and Biotechnology, 2021
As a widely used anticancer drug, doxorubicin (DOX) could induce cell death mainly via interfering with DNA activity; thus, DOX could perform therapeutic effects mainly in the cell nucleus.
Xinyue Song, Xinyue Song, Tao Yan, Feng Tian, Fengyan Li, Linlin Ren, Qiong Li, Qiong Li, Shusheng Zhang   +8 more
doaj   +1 more source

Detection of Tobacco Bacterial Wilt Caused by Ralstonia solanacearum by Combining Polymerase Chain Reaction with an α-Hemolysin Nanopore

Nanomaterials, 2023
Tobacco bacterial wilt is a serious disease caused by the soil-borne bacterium Ralstonia solanacearum (R. solanacearum). Herein, a rapid and purification-free α-hemolysin (α-HL) nanopore-sensing strategy based on polymerase chain reaction (PCR) and ...
Ying Wang, Yusen Li, Xin Zhou, Wenna Zhang, Shusheng Zhang, Dongmei Xi   +5 more
doaj   +1 more source

Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity. [PDF]

, 2020
Although immunotherapies have achieved remarkable salutary effects among subgroups of advanced cancers, most patients do not respond. We comprehensively evaluated biomarkers associated with the "cancer-immunity cycle" in the pan-cancer setting in order ...
Dressman, Devin, Eskander, Ramez, Glenn, Sean T, Goodman, Aaron, Ikeda, Sadakatsu, Kato, Shumei, Kumaki, Yuichi, Kurzrock, Razelle, Lee, Suzanna, Lenzo, Felicia L, Morrison, Carl, Nikanjam, Mina, Okamura, Ryosuke, Papanicolau-Sengos, Antonios   +13 more
core   +1 more source

Tumor markers in breast cancer - European Group on Tumor Markers recommendations [PDF]

, 2005
Recommendations are presented for the routine clinical use of serum and tissue-based markers in the diagnosis and management of patients with breast cancer.
Abraha RS, Andreasen PA, Arie van Dalen, ASCO Expert Panel, Barak V, Barnes DM, Baselga J, Bast RC, Benraad TH, Bieglmayer C, Blamey RW, Bonadonna G, Chan DW, Chebil G, Chu KC, Colditz G, Conneely OM, De Koning H, Devine PL, Dixon AR, Dnistrian AM, Dnistrian AM, Duffy MJ, Duffy MJ, Duffy MJ, Duffy MJ, Duffy MJ, Early Breast Cancer Trialist's, Early Breast Cancer Trialists Collaborative Group, Early Breast Cancer Trialists Collaborative Group, Easton DF, Ebeling FC, Ebeling FG, Eifel P, Einarsson R, Ekbom A, Elledge RM, Fisher B, Fitzgibbons PL, Gion M, Gion M, Guadagni F, Gyö, Harries M, Harvey JM, Helena Goike, Holli K, Holli K, Iwase H, Jager W, Jensen EV, Kamel EM, Konecny G, Kurebayashi J, Lamerz R, Leake R, Leers M, Leers MP, Leers MP, Legha SS, Leyland-Jones B, Look MP, Loomer L, Loprinzi CL, Madigan MP, Marius Nap, Massimo Gion, McCarty, McLaughlin R, Merimsky O, Michael J. Duffy, Mohsin SK, Molina R, Molina R, Molina R, Molina R, Molina R, Molina R, Molina R, Morrow M, Nakata B, Newcomb P, Nicolini A, Nicolini A, Nicolini A, O'Hanlon DM, Paik S, Palazzo S, Parker SL, Parkin DN, Pecking AP, Pertschuk LP, Pertschuk LP, Petra Stieber, Piccart MJ, Price MR, Rafael Molina, Robertson JFR, Robertson JFR, Rogers CE, Roland Einarsson, Rolf Lamerz, Romer M, Rosselli del Turco M, Safi F, Schapira DV, Schapira DV, Sjostrom J, Slamon D, Soletormos G, Soletormos G, Soletormos G, Soletormos G, Stieber P, Sturgeon CM, Sweep CGJ, Tabar L, The GIVIO, The GIVIO, Theriault RL, Thorpe SM, Tomlinson IP, Tondini C, Van Dalen A, Van Dalen A, van Dalen A, van Dalen A, Van Dalen A, van Dalen A, Veronesi U, Vivian Barak, Vizcarra E, Vyzula R, Weihua Z, Williams MR, Yamauchi H, Zucchelli GC   +136 more
core   +1 more source